Literature DB >> 11248606

PROSTASCINT scan for staging prostate cancer.

P H Lange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11248606     DOI： 10.1016/s0090-4295(00)01109-2

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  7 in total

1.  Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.

Authors:  David M Schuster; Bital Savir-Baruch; Peter T Nieh; Viraj A Master; Raghuveer K Halkar; Peter J Rossi; Melinda M Lewis; Jonathon A Nye; Weiping Yu; F DuBois Bowman; Mark M Goodman
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

2.  Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.

Authors:  Ying Chen; Catherine A Foss; Youngjoo Byun; Sridhar Nimmagadda; Mrudula Pullambhatla; James J Fox; Mark Castanares; Shawn E Lupold; John W Babich; Ronnie C Mease; Martin G Pomper
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

3.  Current Clinical Applications of the In-capromab Pendetide Scan (ProstaScint(R) Scan, Cyt-356).

Authors:  M Han; A W Partin
Journal:  Rev Urol       Date:  2001

Review 4.  Imaging localized prostate cancer: current approaches and new developments.

Authors:  Baris Turkbey; Paul S Albert; Karen Kurdziel; Peter L Choyke
Journal:  AJR Am J Roentgenol       Date:  2009-06       Impact factor: 3.959

5.  Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).

Authors:  Sangeeta R Banerjee; Catherine A Foss; Mark Castanares; Ronnie C Mease; Youngjoo Byun; James J Fox; John Hilton; Shawn E Lupold; Alan P Kozikowski; Martin G Pomper
Journal:  J Med Chem       Date:  2008-07-19       Impact factor: 7.446

6.  Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.

Authors:  Eduard Schreibmann; David M Schuster; Peter J Rossi; Joseph Shelton; Sherrie Cooper; Ashesh B Jani
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-04-30       Impact factor: 7.038

Review 7.  Imaging in genitourinary cancer from the urologists' perspective.

Authors:  P Tsakiris; J de la Rosette
Journal:  Cancer Imaging       Date:  2007-05-28       Impact factor: 3.909
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.